Related references
Note: Only part of the references are listed.GABA(A) Receptor Subtypes: Therapeutic Potential in Down Syndrome, Affective Disorders, Schizophrenia, and Autism
Uwe Rudolph et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Antihyperalgesia by α2-GABAA Receptors Occurs Via a Genuine Spinal Action and Does Not Involve Supraspinal Sites
Jolly Paul et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Neural Basis of Benzodiazepine Reward: Requirement for α2 Containing GABAA Receptors in the Nucleus Accumbens
Elif Engin et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Evaluation of Anti-Hyperalgesic and Analgesic Effects of Two Benzodiazepines in Human Experimental Pain: A Randomized Placebo-Controlled Study
Pascal H. Vuilleumier et al.
PLOS ONE (2013)
Chronic Pain States: Pharmacological Strategies to Restore Diminished Inhibitory Spinal Pain Control
Hanns Ulrich Zeilhofer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Assessment of the effects of NS11394 and L-838417, α2/3 subunit-selective GABAA receptor-positive allosteric modulators, in tests for pain, anxiety, memory and motor function
Martine Hofmann et al.
BEHAVIOURAL PHARMACOLOGY (2012)
Selective Distribution of GABAA Receptor Subtypes in Mouse Spinal Dorsal Horn Neurons and Primary Afferents
Jolly Paul et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2012)
Differential Roles of GABAA Receptor Subtypes in Benzodiazepine-Induced Enhancement of Brain-Stimulation Reward
Lauren M. Reynolds et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Benzodiazepine treatment induces subtype-specific changes in GABAA receptor trafficking and decreases synaptic inhibition
Tija C. Jacob et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
J. R. Atack et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Uwe Rudolph et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain
Alessandra Di Lio et al.
NEUROPHARMACOLOGY (2011)
Diazepam Decreases Action Potential Firing of Neocortical Neurons via Two Distinct Mechanisms
Berthold Drexler et al.
ANESTHESIA AND ANALGESIA (2010)
Neural bases for addictive properties of benzodiazepines
Kelly R. Tan et al.
NATURE (2010)
Central mechanisms of pathological pain
Rohini Kuner
NATURE MEDICINE (2010)
Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure
Bradford D. Fischer et al.
NEUROPHARMACOLOGY (2010)
Antiseizure Activity of Novel γ-Aminobutyric Acid (A) Receptor Subtype-Selective Benzodiazepine Analogues in Mice and Rat Models
Felix M. Rivas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The α5(H105R) mutation impairs α5 selective binding properties by altered positioning of the α5 subunit in GABAA receptors containing two distinct types of α subunits
E. Balic et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Models and Mechanisms of Hyperalgesia and Allodynia
Juergen Sandkuehler
PHYSIOLOGICAL REVIEWS (2009)
Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice
Julia Knabl et al.
PAIN (2009)
Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain
G. Munro et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Reversal of pathological pain through specific spinal GABAA receptor subtypes
Julia Knabl et al.
NATURE (2008)
Altered chloride homeostasis in neurological disorders: a new target
Yves De Koninck
CURRENT OPINION IN PHARMACOLOGY (2007)
Impact of subunit positioning on GABAA receptor function
E. Sigel et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors
Jennifer Li et al.
NEUROPHARMACOLOGY (2006)
An inverse agonist selective for α5 subunit-containing GABAA receptors enhances cognition
GR Dawson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Evidence for a significant role of α3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
R Dias et al.
JOURNAL OF NEUROSCIENCE (2005)
Analysis of the presence and abundance of GABAA receptors containing two different types of α subunits in murine brain using point-mutated α subunits
D Benke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Trace fear conditioning involves hippocampal α5 GABAA receptors
F Crestani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Benzodiazepines act an GABAA receptors via two distinct and separable mechanisms
RJ Walters et al.
NATURE NEUROSCIENCE (2000)
Molecular and neuronal substrate for the selective attenuation of anxiety
K Löw et al.
SCIENCE (2000)
Sedative but not anxiolytic properties of benzodiazepines ave mediated by the GABAA receptor α1 subtype
RM McKernan et al.
NATURE NEUROSCIENCE (2000)
Share Paper
